KPIs & Operating Metrics(New)
Growth Metrics

Cvs Health (CVS) Debt to Equity (2016 - 2025)

Cvs Health's Debt to Equity history spans 17 years, with the latest figure at $0.86 for Q4 2025.

  • For the quarter ending Q4 2025, Debt to Equity rose 3.78% year-over-year to $0.86, compared with a TTM value of $0.86 through Dec 2025, up 3.78%, and an annual FY2025 reading of $0.86, up 3.78% over the prior year.
  • Debt to Equity for Q4 2025 was $0.86 at Cvs Health, up from $0.85 in the prior quarter.
  • The five-year high for Debt to Equity was $0.88 in Q2 2024, with the low at $0.7 in Q4 2022.
  • Average Debt to Equity over 5 years is $0.8, with a median of $0.81 recorded in 2023.
  • Year-over-year, Debt to Equity fell 23.05% in 2021 and then increased 18.9% in 2023.
  • Tracing CVS's Debt to Equity over 5 years: stood at $0.75 in 2021, then decreased by 6.3% to $0.7 in 2022, then increased by 9.16% to $0.77 in 2023, then grew by 7.75% to $0.83 in 2024, then grew by 3.78% to $0.86 in 2025.
  • Per Business Quant, the three most recent readings for CVS's Debt to Equity are $0.86 (Q4 2025), $0.85 (Q3 2025), and $0.78 (Q2 2025).